Price Target Analysis Bristol-Myers Squibb Company (BMY)

Beech Hill Advisors Inc increased Bristol Myers Squibb Co (BMY) stake by 533.82% reported in 2017Q3 SEC filing. Tradewinds Capital Management LLC now owns 1,945 shares of the biopharmaceutical company's stock worth $108,000 after buying an additional 500 shares during the last quarter. Chilton Investment Co. LLC now owns 5,283 shares of the biopharmaceutical company's stock valued at $294,000 after purchasing an additional 26 shares during the last quarter. Atlanta Capital Group sold 5,244 shares as Bristol Myers Squibb Co (BMY)'s stock declined 1.04%. The lowest price the stock reached in the last trading day was $1.51 and compares with the $0.78 52-week low. About 3.10M shares traded. It has underperformed by 39.89% the S&P500.

Comparing the number of shares sold short to the float is a method analysts often use to get a reading on investor sentiment. Its up 0.08, from 0.95 in 2017Q2.

Several other institutional investors have also sold shares of the company. LLC raised its stake in shares of Bristol-Myers Squibb by 523.5% in the third quarter. Rhumbline Advisers owns 2.62 million shares. About 5.10M shares traded. 70,835 were accumulated by Cetera Advsrs Ltd Liability Com. Girard Ltd holds 0.4% or 30,104 shares. The current share price of Bristol-Myers Squibb Company is valued at $62.01 with a change in price of 0.26%. Gfs Advsrs Ltd Limited Liability Company owns 4,811 shares or 0.07% of their U.S. portfolio. Jane Street Gru Limited Com reported 61,013 shares or 0.01% of all its holdings. Rafferty Asset Mngmt Limited Liability Corp owns 47,642 shares. (NYSE:AIN). Kennedy Cap Management Incorporated owns 240,548 shares. That's a potential 2.29 increase relative to where Bristol-Myers Squibb Company (NYSE:BMY) has been trading recently. Finemark Fincl Bank & has invested 0.54% in Bristol-Myers Squibb Company (NYSE:BMY). 0 analysts gave its stock an Outperform rating. Suntrust Banks has 0.04% invested in The Sherwin-Williams Company (NYSE:SHW) for 18,754 shares. Benchmark Capital Advisors, a New York-based fund reported 98,034 shares.#img1#. Therefore 32% are positive. Orion Engineered Carbons had 19 analyst reports since August 10, 2015 according to SRatingsIntel. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since January 11, 2017 and is downtrending. The firm has "Hold" rating by Jefferies given on Thursday, July 14. The firm earned "Neutral" rating on Tuesday, January 17 by Seaport Global Securities. The stock has "Market Perform" rating by Raymond James on Wednesday, September 21. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the stock. Barclays Capital maintained the stock with "Equal-Weight" rating in Friday, October 13 report. Cowen reiterated a "hold" rating and issued a $65.00 price objective on shares of Bristol-Myers Squibb in a report on Tuesday, September 19th. Earnest Partners stated it has 1.15 million shares or 0.66% of all its holdings.

Aviance Capital Management Llc, which manages about $2.20B and $1.45 billion US Long portfolio, upped its stake in Bce Inc Com New (NYSE:BCE) by 75,323 shares to 75,458 shares, valued at $3.53M in 2017Q3, according to the filing. Zacks Investment Research downgraded Bristol-Myers Squibb Company from a "buy" rating to a "hold" rating in a report on Monday, January 9th. The insider Lynch Thomas J. Jr. sold 5,300 shares worth $335,172. On Thursday, August 11 the stock rating was downgraded by Berenberg to "Hold". Therefore 41% are positive. Albany Intl had 4 analyst reports since October 29, 2015 according to SRatingsIntel.

Piper Jaffray now has a $60.0 price target on shares of Bristol Myers (NYSE:BMY). The company was maintained on Friday, October 6 by UBS. JMP Securities upgraded the stock to "Market Outperform" rating in Wednesday, May 24 report. On Wednesday, October 18 the stock rating was maintained by Citigroup with "Buy". Wall Street is only getting more bullish on the stock, with 10 of analysts who cover BMY having a buy-equivalent rating. The company was downgraded on Tuesday, September 12 by Hilliard Lyons. As per Friday, April 29, the company rating was upgraded by Standpoint Research.

Investors sentiment decreased to 1.02 in Q3 2017. Its up 0.13, from 1.13 in 2017Q2. It improved, as 36 investors sold AOS shares while 132 reduced holdings. 20 funds opened positions while 58 raised stakes. (NASDAQ:FSLR) to report earnings on February, 20. (NYSE:NBL). Korea Invest Corp invested in 11,002 shares. Moreover, Hudson Bay Cap Limited Partnership has 0.08% invested in Bristol-Myers Squibb Company (NYSE:BMY). This is an increase from Bristol-Myers Squibb's previous quarterly dividend of $0.39. (NYSE:VMI). Shell Asset Management Comm has invested 0.02% of its portfolio in Valmont Industries, Inc. Bainco Intll Invsts holds 0.85% or 111,550 shares in its portfolio.

Shares of The AES Corporation (NYSE:AES) have seen a movement of 0.19% in the most recent session. 1,400 are held by First Interstate Bank & Trust. Cibc World Mkts, Ontario - Canada-based fund reported 296,341 shares. Ameritas Inv holds 0.02% in A. O. Smith Corporation (NYSE:AOS) or 7,695 shares. 59,924 are owned by Ar Asset Management. Seaward Lp holds 14,484 shares. It also reduced its holding in Vanguard Index Fds (VOO) by 13,855 shares in the quarter, leaving it with 28,817 shares, and cut its stake in Mettler Toledo International (NYSE:MTD). The earning yield also gives right direction to lure investment, as the co has 2.58% dividend yield. Shares for $3.24 million were sold by JONES PAUL W on Thursday, August 3.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Altre Notizie